Novo Common Stock Total Equity from 2010 to 2026
| NVOS Stock | USD 0 0.0004 11.43% |
Common Stock Total Equity | First Reported 2005-02-28 | Previous Quarter 23.8 K | Current Value 26.5 K | Quarterly Volatility 111.6 K |
Check Novo Integrated financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novo Integrated's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 558.2 K or Selling General Administrative of 17 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 16.85. Novo financial statements analysis is a perfect complement when working with Novo Integrated Valuation or Volatility modules.
Novo | Common Stock Total Equity | Build AI portfolio with Novo Stock |
The evolution of Common Stock Total Equity for Novo Integrated Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Novo Integrated compares to historical norms and industry peers.
Latest Novo Integrated's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Novo Integrated Sciences over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Novo Integrated's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novo Integrated's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Novo Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 208,490 | |
| Geometric Mean | 160,215 | |
| Coefficient Of Variation | 48.50 | |
| Mean Deviation | 71,900 | |
| Median | 234,662 | |
| Standard Deviation | 101,113 | |
| Sample Variance | 10.2B | |
| Range | 356K | |
| R-Value | 0.23 | |
| Mean Square Error | 10.3B | |
| R-Squared | 0.05 | |
| Significance | 0.38 | |
| Slope | 4,556 | |
| Total Sum of Squares | 163.6B |
Novo Common Stock Total Equity History
About Novo Integrated Financial Statements
Novo Integrated shareholders use historical fundamental indicators, such as Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Novo Integrated investors may analyze each financial statement separately, they are all interrelated. The changes in Novo Integrated's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novo Integrated's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 269.9 K | 140.2 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novo Stock Analysis
When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.